Medical specialist services

Tender description

The iABC-consortium (inhaled Antibiotics in Bronchiectasis and Cystic fibrosis) brings together world leading researchers to develop new antibiotic treatment options for people with Cystic Fibrosis (CF) and Bronchiectasis (BE), by sharing expertise and resources. The iABC program provides a unique opportunity to address a critical bottleneck in the development of antimicrobial agents for the treatment of chronic lung infection in CF and BE patients. This work has the potential to deliver new treatments which will improve quality of life and survival of CF and BE patients. As part of this program, Queens University Belfast seeks to appoint an Economic Operator to provide services to conduct Liposomal Formulation of a Peptiide for Inhalation sponsored by Polyphor Ltd. The iABC-consortium (inhaled Antibiotics in Bronchiectasis and Cystic fibrosis) brings together world leading researchers to develop new antibiotic treatment options for people with Cystic Fibrosis (CF) and Bronchiectasis (BE), by sharing expertise and resources. The iABC program provides a unique opportunity to address a critical bottleneck in the development of antimicrobial agents for the treatment of chronic lung infection in CF and BE patients. This work has the potential to deliver new treatments which will improve quality of life and survival of CF and BE patients. As part of this program, Queens University Belfast seeks to appoint an Economic Operator to provide services to conduct Liposomal Formulation of a Peptiide for Inhalation sponsored by Polyphor Ltd. Applicants seeking to obtain tender documents must first complete and submit a Confidential Disclosure Agreement (CDA). Please note: tender documents will not be issued to any applicant until they have first submitted a completed CDA to Queen's University Belfast via the electronic tendering system outlined within this notice. The CDA may be obtained from the contact details outlined within this notice. It is anticipated that all applicants who have completed a CDA will receive tender documentation on 1.5.2019, with a closing date for receipt of tenders on 3.6.2019 at 4:00 p.m. (BST).